BioWorld: Harvard spin-out targets circulating factor for tissue rejuvenation

Sept. 6, 2018 - A series of eye-catching papers on parabiosis experiments in mice, which identified a circulating protein that reverses aging-related tissue degeneration, has led to the formation of a new Harvard University spin-out, Elevian Inc., which has just closed a seed round of $5.5 million.

(Purchase required for full article)

Read More →

Press About UsMark Allen